Entero Healthcare Solutions Limited
NSE: ENTEROINE010601016·Consumer ServicesMicrocap 250·www.enterohealthcare.com ↗·Mcap ₹8,023 Cr·Listed 2024
₹1,821.80▼ ₹30.40  (−1.64%)
52W: ₹944 – ₹1,920 · Vol: 1.1L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q3 FY24
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24
Revenue from operations1,9401,9101,7071,5711,4041,3391,3591,3011,0971,034993
Other income344.64.85.87.37.511.313.49.11.8
Total expenses1,8761,8561,6631,5311,3731,3091,3271,2771,0831,030986
EBITDA978667.862.150.148.95042.430.228.928.6
EBITDA margin5.0%4.5%4.0%4.0%3.6%3.7%3.7%3.3%2.8%2.8%2.9%
Finance costs20.617.31412.410.710.51011.59.717.316.1
Depreciation12.314.89.89.88.98.58.17.56.67.16
Profit before tax67.157.940.444.636.437.239.434.827.313.68.3
Tax15.112.86.586.15.8108.76.8−7.61.3
Net profit52.145.133.936.630.231.429.42620.521.27
Net margin2.7%2.4%2.0%2.3%2.2%2.3%2.2%2.0%1.9%2.0%0.7%
EPS (₹)8.776.446.357.266.395.915.855.434.625.731.91
Net profit YoY+72.2%+43.6%+15.0%+40.6%+47.3%+48.4%+321.8%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24
Revenue from operations6,5915,0963,922
Other income19.239.514.4
Total expenses6,4234,9973,901
EBITDA266172112
EBITDA margin4.0%3.4%2.9%
Finance costs54.441.665.7
Depreciation43.330.725
Profit before tax17913935.6
Tax33.531.3−4.2
Net profit14610739.8
Net margin2.2%2.1%1.0%
EPS (₹)26.4421.8010.81
Net profit YoY+35.7%+169.9%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24
Operating cash flow96.2−76.9−36.6
Investing cash flow−303220−705
Financing cash flow124−73.7863
Capital expenditure67.511.35.4
Free cash flow (CFO − capex)28.7−88.2−42

Net profit trend

annual, ₹ crore
FY24
₹39.8
FY25
₹107+170%
FY26
₹146+36%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated7 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone7 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited25 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited25 May 2026PDF on NSE XBRL
Q3 FY26Consolidated12 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone12 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated12 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone12 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated8 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone8 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 63.7×47.3×
P/B5Y avg 3.00×4.69×
ROEFY26, on average equity8.5%
Net margin2.2%
Debt / equity0.34×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹38.53
Market cap₹7,927 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
4.69×
vs 5-point avg 3.00× (+57%)
2.62× low3.00× avg4.69× high
History points are balance-sheet dates (2024 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹3,600 Cr+33%
Net worth₹1,689 Cr−2%
Total borrowings₹567 Cr+90%
Cash & bank balances₹147 Cr−36%
Investments₹130 Cr+126%
Inventories₹842 Cr+28%
Trade receivables₹1,212 Cr+46%
Trade payables₹725 Cr+83%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Feb 24
Promoter52.4052.4252.4252.4252.4252.4252.4452.4452.4452.4452.44
FII4.374.035.1414.6717.2019.9222.2123.8223.3223.3022.80
DII15.4816.6216.429.6510.189.648.777.732.062.282.15
of which MF8.979.5210.254.786.14––––––
Retail13.0612.2511.579.366.995.414.364.065.004.965.73
Other public14.6914.6814.4513.9013.2112.6112.2211.9517.1817.0216.88
39,709 shareholders · NSE shareholding pattern filings.